tirzepatide and bone loss Tirzepatide, a dual GLP-1 GIP receptor agonist, promotes in obese mice via gut microbial-related metabolites Effects of Semaglutide and Tirzepatide

For those not taking GLP-1 medications, these eating habits can naturally support better appetite regulation since GLP-1 slows digestion, allowing us to feel full for longer

In some cases, researchers prefer using a higher initial dose and lower maintenance doses

Starting at lower doses minimizes the risk of severe gastrointestinal side effects and allows individuals to adapt to the peptide's effects on gastric emptying and appetite

A typical stack might be 5 grams of L-Glutamine and 1 gram of L-Carnitine daily

It supports the integrity of the gut lining and may improve symptoms of IBS or leaky gut

Common digestive side effects of tirzepatide When people search tirzepatide digestive issues, theyre usually describing a cluster of temporary symptoms that may include nausea, stomach upset, bloating, reflux/heartburn, constipation, or diarrhea